DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 27 (12) , 2515-2523
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (NSFC 81572516, 81572520 JF, 2008ZDKJ-63)
- Scientific and Technological Innovation Project of Shaanxi Province, China
This publication has 37 references indexed in Scilit:
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013European Urology, 2013
- The Mechanism of DAB2IP in Chemoresistance of Prostate Cancer CellsClinical Cancer Research, 2013
- EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for SurvivalClinical Cancer Research, 2012
- Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancerJournal of Hepatology, 2011
- Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasisProceedings of the National Academy of Sciences, 2010
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancerMolecular Cancer, 2010
- DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosisProceedings of the National Academy of Sciences, 2009
- Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survivalMolecular Cancer, 2008
- Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic FunctionJournal of Biological Chemistry, 2008
- Sonic and desert hedgehog signaling in human fetal prostate developmentThe Prostate, 2007